Does bolusing intravenous administration sets with monoclonal antibodies reduce chair time in the oncology outpatient setting? a protocol for a randomized controlled trial.
Introduction: Commencing prescribed drugs at the prescribed rate without bolusing the intravenous (IV) administration set with the drug, can increase the time patients spend receiving their treatment. There is an absence of research reporting on bolusing practices in the oncology setting. Clinical O...
| Publicado en: | Vascular Access Vol. 17; no. 3; pp. 8 - 24 |
|---|---|
| Autores principales: | , , , , , , , , , |
| Formato: | protocol tables/charts Journal Article |
| Publicado: |
Canadian Vascular Access Association
Fall/Winter2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |